Cha DR - Search Results

1

Blood Pressure Control in Patients with Diabetic Kidney Disease.

Kim Y, Kim W, Kim JK, Moon JY, Park S, Park CW, Park HS, Song SH, Yoo TH, Lee SY, Lee EY, Lee J, Jin K, Cha DR, Cha JJ, Han SY; Korean Diabetic Kidney Disease Working Group. Kim Y, et al. Among authors: cha jj, cha dr. Electrolyte Blood Press. 2022 Dec;20(2):39-48. doi: 10.5049/EBP.2022.20.2.39. Epub 2022 Dec 30. Electrolyte Blood Press. 2022. PMID: 36688208 Free PMC article. Review.

2

ACE gene polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients.

Han SY, Kwon YJ, Jo SK, Shin JH, Cha DR, Cho WY, Pyo HJ, Kim HK. Han SY, et al. Among authors: cha dr. Korean J Intern Med. 2000 Jan;15(1):13-8. doi: 10.3904/kjim.2000.15.1.13. Korean J Intern Med. 2000. PMID: 10714086 Free PMC article.

3

alpha-Melanocyte stimulating hormone (MSH) decreases cyclosporine a induced apoptosis in cultured human proximal tubular cells.

Jo SK, Lee SY, Han SY, Cha DR, Cho WY, Kim HK, Won NH. Jo SK, et al. Among authors: cha dr. J Korean Med Sci. 2001 Oct;16(5):603-9. doi: 10.3346/jkms.2001.16.5.603. J Korean Med Sci. 2001. PMID: 11641530 Free PMC article.

4

Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.

Kim NH, Kim KB, Kim DL, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR. Kim NH, et al. Among authors: cha dr. Diabet Med. 2004 Jun;21(6):545-51. doi: 10.1111/j.1464-5491.2004.01200.x. Diabet Med. 2004. PMID: 15154937

5

Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.

Cha DR, Kang YS, Han SY, Jee YH, Han KH, Han JY, Kim YS, Kim NH. Cha DR, et al. J Endocrinol. 2004 Oct;183(1):183-94. doi: 10.1677/joe.1.05647. J Endocrinol. 2004. PMID: 15525586

6

Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.

Cha DR, Kim IS, Kang YS, Han SY, Han KH, Shin C, Ji YH, Kim NH. Cha DR, et al. Diabet Med. 2005 Jan;22(1):14-20. doi: 10.1111/j.1464-5491.2004.01295.x. Diabet Med. 2005. PMID: 15606685

7

Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy.

Kim NH, Oh JH, Seo JA, Lee KW, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR. Kim NH, et al. Among authors: cha dr. Kidney Int. 2005 Jan;67(1):167-77. doi: 10.1111/j.1523-1755.2005.00067.x. Kidney Int. 2005. PMID: 15610240 Free article.

8

Characteristics of population with normal serum creatinine impaired renal function and: the validation of a MDRD formula in a healthy general population.

Kang YS, Han KH, Han SY, Kim HK, Cha DR. Kang YS, et al. Among authors: cha dr. Clin Nephrol. 2005 Apr;63(4):258-66. doi: 10.5414/cnp63258. Clin Nephrol. 2005. PMID: 15847252

9

Role of aldosterone in diabetic nephropathy.

Cha DR, Kang YS, Han SY, Jee YH, Han KH, Kim HK, Han JY, Kim YS. Cha DR, et al. Nephrology (Carlton). 2005 Oct;10 Suppl:S37-9. doi: 10.1111/j.1440-1797.2005.00455.x. Nephrology (Carlton). 2005. PMID: 16174286

10

High glucose and angiotensin II increase beta1 integrin and integrin-linked kinase synthesis in cultured mouse podocytes.

Han SY, Kang YS, Jee YH, Han KH, Cha DR, Kang SW, Han DS. Han SY, et al. Among authors: cha dr. Cell Tissue Res. 2006 Feb;323(2):321-32. doi: 10.1007/s00441-005-0065-4. Epub 2005 Sep 28. Cell Tissue Res. 2006. PMID: 16189717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page